Intra Cellular Therapies shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Intra Cellular Therapies by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $9.7M | 135k | 71.62 |
2023-09-30 | $7.1M | 137k | 52.09 |
2023-06-30 | $8.5M | 135k | 63.32 |
2023-03-31 | $6.9M | 128k | 54.15 |
2022-12-31 | $6.8M | 128k | 52.92 |
2022-09-30 | $5.7M | 122k | 46.53 |
2022-06-30 | $6.4M | 112k | 57.08 |
2022-03-31 | $5.4M | 88k | 61.18 |
2021-12-31 | $4.0M | 76k | 52.34 |
2021-09-30 | $2.9M | 77k | 37.28 |
2021-06-30 | $3.0M | 74k | 40.82 |
2021-03-31 | $3.2M | 94k | 33.93 |
2020-12-31 | $3.2M | 102k | 31.80 |
2020-09-30 | $2.3M | 90k | 25.66 |
2020-06-30 | $2.6M | 101k | 25.67 |
2020-03-31 | $1.3M | 82k | 15.37 |
2019-12-31 | $2.3M | 68k | 34.30 |
2019-09-30 | $503k | 67k | 7.47 |
2019-06-30 | $826k | 64k | 12.99 |
2019-03-31 | $735k | 60k | 12.18 |
2018-12-31 | $693k | 61k | 11.38 |
2018-09-30 | $920k | 42k | 21.70 |
2018-06-30 | $912k | 52k | 17.68 |
2018-03-31 | $901k | 43k | 21.04 |
2017-12-31 | $625k | 43k | 14.47 |
2017-09-30 | $689k | 44k | 15.78 |
2017-06-30 | $538k | 43k | 12.43 |
2017-03-31 | $680k | 42k | 16.25 |
2016-12-31 | $610k | 40k | 15.10 |
2016-09-30 | $587k | 39k | 15.25 |
2016-06-30 | $1.3M | 33k | 38.82 |
2016-03-31 | $728k | 26k | 27.80 |
2015-12-31 | $1.4M | 26k | 53.80 |
2015-09-30 | $767k | 19k | 40.04 |
2015-06-30 | $590k | 19k | 31.97 |
2015-03-31 | $357k | 15k | 23.87 |
2014-12-31 | $215k | 12k | 17.69 |
2014-09-30 | $161k | 12k | 13.73 |
2014-06-30 | $198k | 12k | 16.88 |